Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontranscription coactivator activity

NCOA2 TRIM24 SMARCC2 NCOA3 TOX3 NCOA6

9.94e-09303126GO:0003713
GeneOntologyMolecularFunctiontranscription coregulator activity

NCOA2 TRIM24 SMARCC2 NCOA3 TOX3 NCOA6

3.87e-07562126GO:0003712
GeneOntologyMolecularFunctionnuclear thyroid hormone receptor binding

NCOA2 NCOA3 NCOA6

9.82e-0734123GO:0046966
GeneOntologyMolecularFunctionchromatin binding

NCOA2 TRIM24 SMARCC2 NCOA3 TOX3 NCOA6

1.92e-06739126GO:0003682
GeneOntologyMolecularFunctionnuclear receptor binding

NCOA2 TRIM24 NCOA3 NCOA6

3.48e-06187124GO:0016922
GeneOntologyMolecularFunctionnuclear estrogen receptor binding

NCOA2 NCOA3 NCOA6

3.82e-0653123GO:0030331
GeneOntologyMolecularFunctionmolecular adaptor activity

NCOA2 TRIM24 SMARCC2 GIGYF2 NCOA3 TOX3 NCOA6

3.84e-061356127GO:0060090
GeneOntologyMolecularFunctionnuclear receptor coactivator activity

NCOA2 NCOA3 NCOA6

5.85e-0661123GO:0030374
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

NCOA2 TRIM24 SMARCC2 NCOA3 TOX3 NCOA6

2.59e-051160126GO:0030674
GeneOntologyMolecularFunctionnuclear glucocorticoid receptor binding

NCOA2 NCOA6

6.25e-0520122GO:0035259
GeneOntologyMolecularFunctionperoxisome proliferator activated receptor binding

NCOA3 NCOA6

6.91e-0521122GO:0042975
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

NCOA2 TRIM24 NCOA3 NCOA6

8.13e-05417124GO:0061629
GeneOntologyMolecularFunctionnuclear retinoid X receptor binding

NCOA2 NCOA6

8.32e-0523122GO:0046965
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

NCOA2 TRIM24 NCOA3 NCOA6

2.93e-04582124GO:0140297
GeneOntologyMolecularFunctionnuclear retinoic acid receptor binding

NCOA2 NCOA6

4.83e-0455122GO:0042974
GeneOntologyMolecularFunctiontranscription factor binding

NCOA2 TRIM24 NCOA3 NCOA6

7.79e-04753124GO:0008134
GeneOntologyMolecularFunctionchromatin DNA binding

SMARCC2 TOX3

4.34e-03167122GO:0031490
GeneOntologyMolecularFunctionprotein dimerization activity

NCOA2 TFEB NCOA3 TOX3

4.42e-031205124GO:0046983
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

NCOA2 TRIM24 TFEB NCOA3

8.73e-031459124GO:0000977
GeneOntologyMolecularFunctionhistone binding

TRIM24 SMARCC2

1.06e-02265122GO:0042393
GeneOntologyMolecularFunctionprotein domain specific binding

NCOA2 NCOA3 NCOA6

1.37e-02875123GO:0019904
GeneOntologyBiologicalProcessembryonic placenta development

TFEB NCOA3 NCOA6

3.97e-05119123GO:0001892
GeneOntologyBiologicalProcesspositive regulation of intracellular steroid hormone receptor signaling pathway

NCOA2 NCOA3

4.72e-0518122GO:0033145
GeneOntologyBiologicalProcesspositive regulation of transcription by RNA polymerase II

PAXIP1 NCOA2 TFEB NCOA3 TOX3 NCOA6

6.01e-051390126GO:0045944
GeneOntologyBiologicalProcessplacenta development

TFEB NCOA3 NCOA6

1.77e-04197123GO:0001890
GeneOntologyBiologicalProcessnuclear receptor-mediated signaling pathway

NCOA2 TRIM24 NCOA3

1.91e-04202123GO:0141193
GeneOntologyBiologicalProcessin utero embryonic development

TFEB PRRC2B NCOA3 NCOA6

2.84e-04596124GO:0001701
GeneOntologyBiologicalProcesshormone-mediated signaling pathway

NCOA2 TRIM24 NCOA3

3.32e-04244123GO:0009755
GeneOntologyBiologicalProcesslabyrinthine layer development

NCOA3 NCOA6

6.13e-0464122GO:0060711
GeneOntologyCellularComponentMLL3/4 complex

PAXIP1 NCOA6

1.99e-0512122GO:0044666
GeneOntologyCellularComponenttranscription regulator complex

NCOA2 TFEB NCOA3 NCOA6

2.70e-04596124GO:0005667
GeneOntologyCellularComponentnuclear protein-containing complex

PAXIP1 NCOA2 SMARCC2 NCOA3 NCOA6

6.59e-041377125GO:0140513
GeneOntologyCellularComponenthistone methyltransferase complex

PAXIP1 NCOA6

8.19e-0475122GO:0035097
GeneOntologyCellularComponentchromatin

NCOA2 TRIM24 TFEB SMARCC2 NCOA3

9.18e-041480125GO:0000785
GeneOntologyCellularComponentmethyltransferase complex

PAXIP1 NCOA6

1.69e-03108122GO:0034708
GeneOntologyCellularComponentnuclear matrix

PAXIP1 SMARCC2

2.81e-03140122GO:0016363
GeneOntologyCellularComponentnuclear periphery

PAXIP1 SMARCC2

4.16e-03171122GO:0034399
GeneOntologyCellularComponentRNA polymerase II transcription regulator complex

NCOA2 NCOA3

1.02e-02272122GO:0090575
GeneOntologyCellularComponentnuclear body

SCAF11 NCOA2 BMP2K

1.32e-02903123GO:0016604
DomainDUF4927

NCOA2 NCOA3

3.78e-072122IPR032565
DomainDUF4927

NCOA2 NCOA3

3.78e-072122PF16279
DomainDUF1518

NCOA2 NCOA3

1.13e-063122SM01151
DomainNuc_rcpt_coact_Ncoa-typ

NCOA2 NCOA3

1.13e-063122IPR014920
DomainSRC-1

NCOA2 NCOA3

1.13e-063122IPR014935
DomainSRC-1

NCOA2 NCOA3

1.13e-063122PF08832
DomainDUF1518

NCOA2 NCOA3

1.13e-063122PF07469
Domain-

NCOA2 NCOA3

1.13e-0631224.10.630.10
DomainDUF1518

NCOA2 NCOA3

1.13e-063122IPR010011
DomainNuc_rec_co-act

NCOA2 NCOA3

1.13e-063122PF08815
DomainSrc1_rcpt_coact

NCOA2 NCOA3

1.13e-063122IPR008955
DomainNuclear_rcpt_coactivator

NCOA2 NCOA3

1.13e-063122IPR017426
DomainNuc_rcpt_coact

NCOA2 NCOA3

5.67e-066122IPR009110
Domain-

NCOA2 TFEB NCOA3

4.09e-051091234.10.280.10
DomainHLH

NCOA2 TFEB NCOA3

4.93e-05116123SM00353
DomainBHLH

NCOA2 TFEB NCOA3

5.06e-05117123PS50888
DomainbHLH_dom

NCOA2 TFEB NCOA3

5.19e-05118123IPR011598
DomainPAS

NCOA2 NCOA3

1.13e-0425122PF00989
DomainPAS_fold

NCOA2 NCOA3

1.13e-0425122IPR013767
DomainBRCT_dom

PAXIP1 SMARCC2

1.42e-0428122IPR001357
DomainPAS

NCOA2 NCOA3

1.86e-0432122SM00091
DomainPAS

NCOA2 NCOA3

2.10e-0434122IPR000014
DomainPAS

NCOA2 NCOA3

2.10e-0434122PS50112
DomainHLH

TFEB NCOA3

2.22e-03111122PF00010
DomainZnf_RING_CS

SCAF11 TRIM24

4.72e-03163122IPR017907
DomainZF_RING_1

SCAF11 TRIM24

1.44e-02291122PS00518
DomainZF_RING_2

SCAF11 TRIM24

1.51e-02298122PS50089
DomainRING

SCAF11 TRIM24

1.57e-02305122SM00184
DomainZnf_RING

SCAF11 TRIM24

1.79e-02326122IPR001841
Domain-

SCAF11 TRIM24

3.25e-024491223.30.40.10
DomainZnf_RING/FYVE/PHD

SCAF11 TRIM24

3.38e-02459122IPR013083
PathwayWP_KLEEFSTRA_SYNDROME

PAXIP1 SMARCC2 NCOA6

1.28e-0629113M48076
PathwayKEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY

NCOA2 NCOA3

3.03e-0511112M47503
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION

NCOA2 NCOA3 NCOA6

3.25e-0584113M1008
PathwayPID_ERB_GENOMIC_PATHWAY

NCOA2 NCOA3

5.78e-0515112M119
PathwayREACTOME_ADIPOGENESIS

NCOA2 NCOA3 NCOA6

7.29e-05110113M48259
PathwayREACTOME_RORA_ACTIVATES_GENE_EXPRESSION

NCOA2 NCOA6

8.41e-0518112M26942
PathwayREACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA

NCOA2 NCOA3 NCOA6

8.98e-05118113M27316
PathwayREACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS

PAXIP1 NCOA3 NCOA6

9.92e-05122113M29689
PathwayREACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION

NCOA2 NCOA6

1.92e-0427112M26943
PathwayPID_RETINOIC_ACID_PATHWAY

NCOA2 NCOA3

2.38e-0430112M207
PathwayWP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY

NCOA2 NCOA6

2.54e-0431112M39476
PathwayWP_PREGNANE_X_RECEPTOR_PATHWAY

NCOA2 NCOA3

2.71e-0432112M39567
PathwayREACTOME_DEVELOPMENTAL_BIOLOGY

PAXIP1 NCOA2 TFEB SMARCC2 NCOA3 NCOA6

3.20e-041432116M509
PathwayREACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES

PAXIP1 NCOA6

4.69e-0442112M48018
PathwayREACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP

NCOA2 NCOA6

4.69e-0442112M27172
PathwayREACTOME_HEME_SIGNALING

NCOA2 NCOA6

6.38e-0449112M41832
PathwayPID_AR_TF_PATHWAY

NCOA2 TRIM24

7.46e-0453112M151
PathwayREACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS

NCOA2 NCOA6

8.04e-0455112M27145
PathwayREACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF

NCOA2 NCOA6

8.04e-0455112M27001
PathwayREACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION

PAXIP1 SMARCC2 NCOA6

8.57e-04254113M27131
PathwayREACTOME_CYTOPROTECTION_BY_HMOX1

NCOA2 NCOA6

9.56e-0460112M41830
PathwayPID_AR_PATHWAY

NCOA2 NCOA6

9.88e-0461112M58
PathwayPID_ERA_GENOMIC_PATHWAY

NCOA2 NCOA3

1.09e-0364112M200
PathwayREACTOME_CIRCADIAN_CLOCK

NCOA2 NCOA6

1.30e-0370112M938
PathwayWP_NUCLEAR_RECEPTORS_METAPATHWAY

NCOA2 NCOA3 NCOA6

1.58e-03314113M39428
PathwayPID_REG_GR_PATHWAY

NCOA2 SMARCC2

1.78e-0382112M115
PathwayWP_ANDROGEN_RECEPTOR_SIGNALING

NCOA2 NCOA3

2.18e-0391112M39700
PathwayREACTOME_MITOCHONDRIAL_BIOGENESIS

NCOA2 NCOA6

2.43e-0396112M26973
PathwayREACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT

TFEB SMARCC2

4.87e-03137112M48232
PathwayREACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION

NCOA2 NCOA3

5.73e-03149112M27888
PathwayREACTOME_METABOLISM_OF_STEROIDS

NCOA2 NCOA6

6.11e-03154112M27832
PathwayREACTOME_CHROMATIN_MODIFYING_ENZYMES

NCOA2 SMARCC2

7.83e-03175112MM14941
PathwayREACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS

NCOA2 NCOA6

1.11e-02210112M41836
PathwayREACTOME_ESR_MEDIATED_SIGNALING

NCOA2 NCOA3

1.22e-02220112M27794
PathwayREACTOME_CHROMATIN_MODIFYING_ENZYMES

NCOA2 SMARCC2

1.82e-02272112M29619
PathwayREACTOME_METABOLISM_OF_LIPIDS

NCOA2 NCOA3 NCOA6

1.84e-02757113M27451
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

1.14e-1226812733640491
Pubmed

Interaction network of human early embryonic transcription factors.

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

7.62e-1235112738297188
Pubmed

T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.

NCOA2 TRIM24 NCOA3 NCOA6

3.92e-112012411877444
Pubmed

Human transcription factor protein interaction networks.

PAXIP1 SCAF11 NCOA2 TRIM24 PRRC2B SMARCC2 GIGYF2 NCOA3 NCOA6

6.41e-11142912935140242
Pubmed

cDNAs with long CAG trinucleotide repeats from human brain.

PAXIP1 GIGYF2 NCOA3 TOX3

7.17e-11231249225980
Pubmed

Interactions of RXR with coactivators are differentially mediated by helix 11 of the receptor's ligand binding domain.

NCOA2 TRIM24 NCOA3

1.25e-10412311851396
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

4.95e-1063812731182584
Pubmed

The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.

NCOA2 NCOA3 NCOA6

5.17e-091112336613751
Pubmed

Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.

NCOA2 TRIM24 NCOA3

1.14e-081412311500849
Pubmed

Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.

NCOA2 SMARCC2 NCOA3 NCOA6

1.14e-087812428611094
Pubmed

Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

NCOA2 TRIM24 NCOA3 NCOA6

1.47e-088312428794006
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

2.18e-08110312734189442
Pubmed

Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.

NCOA2 NCOA3 NCOA6

4.16e-082112319596656
Pubmed

Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.

NCOA3 NCOA6

1.09e-0721228758910
Pubmed

A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.

NCOA2 NCOA3

1.09e-07212230048685
Pubmed

Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.

NCOA2 NCOA3

1.09e-07212221220509
Pubmed

Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis.

NCOA2 NCOA3

1.09e-07212226040939
Pubmed

Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Distinct Entity Characterized by Recurrent NCOA2/3 Gene Fusions.

NCOA2 NCOA3

1.09e-07212230273195
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

PAXIP1 NCOA2 TRIM24 SMARCC2 NCOA3

1.42e-0739812535016035
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

NCOA2 TRIM24 PRRC2B NCOA3 NCOA6

2.81e-0745712532344865
Pubmed

The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1.

NCOA2 NCOA3

3.27e-07312211923473
Pubmed

FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.

NCOA2 NCOA3

3.27e-07312215698540
Pubmed

Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.

NCOA2 NCOA3

3.27e-0731229506940
Pubmed

Structure and chromosomal locations of mouse steroid receptor coactivator gene family.

NCOA2 NCOA3

3.27e-07312210501088
Pubmed

Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.

NCOA2 NCOA3

3.27e-07312228390937
Pubmed

The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.

NCOA2 NCOA3

3.27e-07312221035760
Pubmed

Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.

NCOA2 NCOA3

3.27e-07312218845648
Pubmed

The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.

NCOA2 NCOA3

3.27e-07312212138202
Pubmed

Estrogen signaling in colorectal carcinoma microenvironment: expression of ERbeta1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression.

NCOA2 NCOA3

3.27e-07312219277704
Pubmed

Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.

NCOA2 NCOA3

3.27e-07312221059860
Pubmed

Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.

NCOA2 NCOA3

3.27e-07312223927929
Pubmed

Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation.

NCOA2 NCOA3

3.27e-07312219052561
Pubmed

Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.

NCOA2 NCOA3

3.27e-07312221735116
Pubmed

The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.

NCOA2 NCOA3

3.27e-07312216423883
Pubmed

Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.

NCOA2 NCOA3

3.27e-07312216675958
Pubmed

The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.

NCOA2 NCOA3 NCOA6

3.84e-074312326487511
Pubmed

miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.

NCOA2 NCOA3

6.55e-07412226066330
Pubmed

Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.

NCOA2 NCOA3

6.55e-07412226267537
Pubmed

Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.

NCOA2 NCOA3

6.55e-07412212893883
Pubmed

Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?

NCOA2 NCOA3

6.55e-07412219198856
Pubmed

Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.

NCOA2 NCOA3

6.55e-07412219462000
Pubmed

Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.

NCOA2 NCOA3

6.55e-07412222560224
Pubmed

P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.

NCOA2 NCOA3

6.55e-07412218267973
Pubmed

Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.

NCOA2 NCOA3

6.55e-07412215331759
Pubmed

Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.

NCOA2 NCOA3

6.55e-07412219095746
Pubmed

Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2.

NCOA2 NCOA3

6.55e-07412210598588
Pubmed

The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.

NCOA2 NCOA3

6.55e-07412215563469
Pubmed

Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.

NCOA2 NCOA3

6.55e-07412215563453
Pubmed

Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI). Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene.

NCOA2 NCOA3

1.09e-06512210652338
Pubmed

The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.

NCOA2 NCOA3

1.09e-06512210757795
Pubmed

Synthetic retinoids dissociate coactivator binding from corepressor release.

NCOA2 TRIM24

1.09e-06512212503607
Pubmed

Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.

NCOA2 NCOA3

1.09e-06512214966121
Pubmed

Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor.

NCOA2 NCOA3

1.09e-06512218798693
Pubmed

Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.

NCOA2 NCOA3

1.09e-06512212714702
Pubmed

Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.

NCOA2 NCOA3

1.09e-06512212554772
Pubmed

Redundant enhancement of mouse constitutive androstane receptor transactivation by p160 coactivator family members.

NCOA2 NCOA3

1.09e-06512217950690
Pubmed

SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm.

NCOA2 NCOA3

1.09e-06512217476305
Pubmed

Ontogeny of steroid receptor coactivators in the hippocampus and their role in regulating postnatal HPA axis function.

NCOA2 NCOA3

1.09e-06512217854779
Pubmed

Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes.

NCOA2 NCOA3

1.09e-06512218511550
Pubmed

Regulation of transcription by a protein methyltransferase.

NCOA2 NCOA3

1.09e-06512210381882
Pubmed

Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.

NCOA2 NCOA3

1.09e-06512214766010
Pubmed

Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.

NCOA2 NCOA3

1.09e-06512210803578
Pubmed

SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.

NCOA2 NCOA3

1.09e-0651229812974
Pubmed

SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells.

NCOA2 NCOA3

1.09e-06512212514218
Pubmed

Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.

NCOA2 NCOA3

1.09e-06512211376110
Pubmed

Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells.

NCOA2 NCOA3

1.64e-06612216728408
Pubmed

Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.

NCOA2 NCOA3

1.64e-06612216923966
Pubmed

A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.

NCOA2 NCOA3

1.64e-06612216373399
Pubmed

Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines.

NCOA2 NCOA3

1.64e-06612212630920
Pubmed

Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption.

NCOA2 NCOA3

2.29e-06712221195347
Pubmed

BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.

NCOA2 NCOA3

2.29e-06712216860316
Pubmed

Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.

NCOA2 NCOA3

2.29e-06712211477071
Pubmed

The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine.

NCOA2 NCOA3

2.29e-06712212709428
Pubmed

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.

NCOA2 NCOA3

2.29e-0671229192892
Pubmed

Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells.

NCOA2 NCOA3

2.29e-06712211117530
Pubmed

ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication.

PAXIP1 NCOA3

2.29e-06712234144977
Pubmed

Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.

NCOA2 NCOA3

3.05e-06812211971985
Pubmed

The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.

NCOA2 NCOA3

3.05e-06812212082103
Pubmed

Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.

NCOA2 NCOA3

3.05e-06812223178929
Pubmed

Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.

NCOA2 TRIM24

3.05e-0681229774463
Pubmed

Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.

NCOA2 NCOA3

3.05e-06812214747462
Pubmed

Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.

NCOA2 NCOA3

3.05e-06812210490106
Pubmed

Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

PAXIP1 NCOA6

3.05e-06812217178841
Pubmed

Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.

NCOA2 NCOA3

3.05e-06812212145209
Pubmed

Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities.

NCOA2 NCOA3

3.05e-06812211050077
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

SCAF11 SMARCC2 GIGYF2 NCOA3 NCOA6

3.75e-0677412515302935
Pubmed

Regulation of somatic growth by the p160 coactivator p/CIP.

NCOA2 NCOA3

3.92e-06912211087842
Pubmed

Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity.

NCOA2 NCOA3

3.92e-06912214966289
Pubmed

Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.

NCOA2 NCOA3

3.92e-06912215888456
Pubmed

Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.

NCOA2 NCOA3

3.92e-06912215184363
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

NCOA2 TRIM24 TFEB NCOA3 TOX3

4.62e-0680812520412781
Pubmed

Phylogenetic and expression analysis of the basic helix-loop-helix transcription factor gene family: genomic approach to cellular differentiation.

NCOA2 TFEB NCOA3

4.69e-069812318557763
Pubmed

Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.

NCOA2 NCOA3

4.90e-061012215001550
Pubmed

Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.

SMARCC2 NCOA3

4.90e-061012216751102
Pubmed

Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.

SMARCC2 NCOA3

5.99e-061112218003620
Pubmed

Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.

NCOA2 NCOA3

5.99e-061112211704662
Pubmed

Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation.

NCOA2 NCOA3

5.99e-061112216109736
Pubmed

BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation.

SMARCC2 NCOA3

5.99e-061112212917342
Pubmed

The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.

PAXIP1 SCAF11 TRIM24 SMARCC2

7.62e-0639612426687479
Pubmed

Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.

PAXIP1 NCOA6

8.49e-061312217761849
InteractionERG interactions

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

1.40e-11223127int:ERG
InteractionTBXT interactions

PAXIP1 NCOA2 TRIM24 SMARCC2 NCOA3 NCOA6

2.87e-11116126int:TBXT
InteractionSP7 interactions

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

1.23e-10304127int:SP7
InteractionEGR2 interactions

PAXIP1 NCOA2 TRIM24 PRRC2B NCOA3 NCOA6

3.03e-10171126int:EGR2
InteractionKLF5 interactions

PAXIP1 NCOA2 TRIM24 PRRC2B NCOA3 NCOA6

6.69e-10195126int:KLF5
InteractionGATA2 interactions

PAXIP1 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

7.56e-10199126int:GATA2
InteractionSOX7 interactions

PAXIP1 NCOA2 TRIM24 SMARCC2 NCOA3

7.63e-1082125int:SOX7
InteractionFEV interactions

PAXIP1 NCOA2 TRIM24 PRRC2B NCOA3 NCOA6

8.52e-10203126int:FEV
InteractionSOX17 interactions

PAXIP1 NCOA2 TRIM24 NCOA3 NCOA6

1.61e-0995125int:SOX17
InteractionHNF4A interactions

PAXIP1 NCOA2 TRIM24 SMARCC2 NCOA3 NCOA6

5.27e-09275126int:HNF4A
InteractionPPARG interactions

PAXIP1 NCOA2 TRIM24 GIGYF2 NCOA3 NCOA6

1.02e-08307126int:PPARG
InteractionFOS interactions

PAXIP1 NCOA2 TRIM24 SMARCC2 NCOA3 NCOA6

1.12e-08312126int:FOS
InteractionPOU5F1 interactions

PAXIP1 SCAF11 TRIM24 TFEB PRRC2B SMARCC2 GIGYF2

1.16e-08584127int:POU5F1
InteractionSMG7 interactions

PAXIP1 NCOA2 TRIM24 PRRC2B NCOA3 NCOA6

1.28e-08319126int:SMG7
InteractionTPRX2 interactions

PAXIP1 NCOA2 SMARCC2 NCOA6

2.60e-0856124int:TPRX2
InteractionPAX6 interactions

PAXIP1 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

2.90e-08366126int:PAX6
InteractionHNF1B interactions

PAXIP1 NCOA2 TRIM24 PRRC2B NCOA3

5.30e-08190125int:HNF1B
InteractionGCM1 interactions

PAXIP1 PRRC2B SMARCC2 NCOA3

5.75e-0868124int:GCM1
InteractionMYOD1 interactions

PAXIP1 NCOA2 TRIM24 SMARCC2 NCOA3

5.89e-08194125int:MYOD1
InteractionETV4 interactions

PAXIP1 NCOA2 TRIM24 NCOA3

6.10e-0869124int:ETV4
InteractionCRX interactions

PAXIP1 NCOA2 TRIM24 PRRC2B NCOA3

2.25e-07254125int:CRX
InteractionSOX2 interactions

PAXIP1 NCOA2 TRIM24 TFEB PRRC2B SMARCC2 NCOA3 NCOA6

2.31e-071422128int:SOX2
InteractionSOX9 interactions

PAXIP1 SMARCC2 NCOA3 NCOA6

2.42e-0797124int:SOX9
InteractionNR3C1 interactions

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

3.86e-07974127int:NR3C1
InteractionPAX8 interactions

PAXIP1 NCOA2 PRRC2B NCOA3

4.17e-07111124int:PAX8
InteractionTHRA interactions

NCOA2 TRIM24 NCOA3 NCOA6

4.17e-07111124int:THRA
InteractionAR interactions

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

4.37e-07992127int:AR
InteractionTLX3 interactions

PAXIP1 NCOA2 TRIM24 NCOA3 NCOA6

4.42e-07291125int:TLX3
InteractionETS1 interactions

PAXIP1 TRIM24 SMARCC2 NCOA3

5.90e-07121124int:ETS1
InteractionVDR interactions

NCOA2 TRIM24 NCOA3 NCOA6

7.16e-07127124int:VDR
InteractionPAX9 interactions

PAXIP1 NCOA2 NCOA3 NCOA6

7.86e-07130124int:PAX9
InteractionNCOA1 interactions

NCOA2 TRIM24 NCOA3 NCOA6

1.25e-06146124int:NCOA1
InteractionCEBPA interactions

PAXIP1 NCOA2 TRIM24 PRRC2B SMARCC2 NCOA3 NCOA6

2.03e-061245127int:CEBPA
InteractionRXRA interactions

NCOA2 TRIM24 NCOA3 NCOA6

2.24e-06169124int:RXRA
InteractionNR1I3 interactions

NCOA2 TRIM24 NCOA3

2.75e-0648123int:NR1I3
InteractionNR1I2 interactions

NCOA2 NCOA3 NCOA6

2.75e-0648123int:NR1I2
InteractionNUP35 interactions

NCOA2 TRIM24 PRRC2B NCOA3 NCOA6

2.82e-06424125int:NUP35
InteractionNFIC interactions

PAXIP1 SCAF11 TRIM24 NCOA3

5.31e-06210124int:NFIC
InteractionRARA interactions

NCOA2 TRIM24 NCOA3 NCOA6

6.74e-06223124int:RARA
InteractionNR1H2 interactions

NCOA2 NCOA3 NCOA6

7.91e-0668123int:NR1H2
InteractionFOXA1 interactions

PAXIP1 SCAF11 SMARCC2 NCOA3 NCOA6

8.01e-06525125int:FOXA1
InteractionFMR1 interactions

NCOA2 PRRC2B SMARCC2 GIGYF2 NCOA3

8.86e-06536125int:FMR1
InteractionTERF2IP interactions

SCAF11 NCOA2 TRIM24 SMARCC2 NCOA6

1.02e-05552125int:TERF2IP
InteractionESRRB interactions

NCOA2 TFEB SMARCC2 NCOA3

1.27e-05262124int:ESRRB
InteractionMIF interactions

NCOA2 TRIM24 GIGYF2 NCOA3

1.31e-05264124int:MIF
InteractionPGR interactions

NCOA2 TRIM24 NCOA3

1.50e-0584123int:PGR
InteractionCREBBP interactions

NCOA2 TRIM24 SMARCC2 NCOA3 NCOA6

1.52e-05599125int:CREBBP
InteractionIRF4 interactions

PAXIP1 PRRC2B NCOA3

1.55e-0585123int:IRF4
InteractionTNRC6A interactions

TRIM24 PRRC2B GIGYF2 NCOA6

1.65e-05280124int:TNRC6A
InteractionSTAT6 interactions

NCOA2 TRIM24 NCOA3

1.66e-0587123int:STAT6
InteractionKLF15 interactions

NCOA2 TRIM24 PRRC2B NCOA3

1.90e-05290124int:KLF15
InteractionPPARA interactions

NCOA2 NCOA3 NCOA6

1.97e-0592123int:PPARA
InteractionFOXI1 interactions

PAXIP1 TRIM24 NCOA3

1.97e-0592123int:FOXI1
InteractionSOX10 interactions

PAXIP1 NCOA2 NCOA3

1.97e-0592123int:SOX10
InteractionLINC02910 interactions

SCAF11 PRRC2B GIGYF2

2.16e-0595123int:LINC02910
InteractionCARM1 interactions

NCOA2 TFEB SMARCC2 NCOA3

2.97e-05325124int:CARM1
InteractionKLF8 interactions

NCOA2 TRIM24 PRRC2B NCOA3

3.11e-05329124int:KLF8
InteractionFBXW7 interactions

PAXIP1 SCAF11 SMARCC2 GIGYF2 NCOA3 NCOA6

3.20e-051215126int:FBXW7
InteractionTBR1 interactions

PAXIP1 NCOA2 NCOA3

3.64e-05113123int:TBR1
InteractionSRCAP interactions

NCOA2 TRIM24 SMARCC2

5.16e-05127123int:SRCAP
InteractionSMAD2 interactions

PAXIP1 SMARCC2 NCOA3 NCOA6

5.75e-05385124int:SMAD2
InteractionSOX15 interactions

PAXIP1 NCOA2 NCOA3

7.04e-05141123int:SOX15
InteractionNCOA2 interactions

NCOA2 NCOA3 NCOA6

7.04e-05141123int:NCOA2
InteractionEP300 interactions

PAXIP1 NCOA2 TRIM24 SMARCC2 NCOA3 NCOA6

7.16e-051401126int:EP300
InteractionGTF2E1 interactions

TRIM24 SMARCC2 NCOA3

7.50e-05144123int:GTF2E1
InteractionNCOA6 interactions

PAXIP1 NCOA2 NCOA6

7.65e-05145123int:NCOA6
InteractionATXN1L interactions

SCAF11 PRRC2B SMARCC2

8.46e-05150123int:ATXN1L
InteractionH4C16 interactions

NCOA2 TRIM24 NCOA3

8.80e-05152123int:H4C16
InteractionSOX6 interactions

NCOA2 NCOA3 TOX3

9.69e-05157123int:SOX6
InteractionSMAD3 interactions

TRIM24 SMARCC2 NCOA3 NCOA6

1.03e-04447124int:SMAD3
InteractionMAFA interactions

PAXIP1 NCOA6

1.13e-0427122int:MAFA
InteractionLHX4 interactions

PAXIP1 NCOA2 TRIM24

1.14e-04166123int:LHX4
InteractionNRIP1 interactions

NCOA2 TRIM24 NCOA3

1.23e-04170123int:NRIP1
InteractionPRMT1 interactions

SCAF11 NCOA2 PRRC2B GIGYF2 NCOA3

1.24e-04929125int:PRMT1
InteractionJUN interactions

NCOA2 SMARCC2 NCOA3 NCOA6

1.25e-04470124int:JUN
InteractionAGO2 interactions

TRIM24 PRRC2B GIGYF2 NCOA6

1.27e-04472124int:AGO2
InteractionETV1 interactions

NCOA2 NCOA3

1.31e-0429122int:ETV1
InteractionTLX1 interactions

PAXIP1 NCOA2 NCOA3

1.34e-04175123int:TLX1
InteractionWDHD1 interactions

PAXIP1 NCOA2 GIGYF2

1.38e-04177123int:WDHD1
InteractionALG13 interactions

NCOA2 PRRC2B NCOA3

1.53e-04183123int:ALG13
InteractionLHX2 interactions

PAXIP1 TRIM24 SMARCC2

1.53e-04183123int:LHX2
InteractionTHRB interactions

NCOA2 NCOA3 NCOA6

1.60e-04186123int:THRB
InteractionGATA3 interactions

PAXIP1 PRRC2B NCOA3

1.63e-04187123int:GATA3
InteractionNFIA interactions

PAXIP1 NCOA2 NCOA3

1.65e-04188123int:NFIA
InteractionSMC5 interactions

SCAF11 TRIM24 SMARCC2 GIGYF2 NCOA6

1.76e-041000125int:SMC5
InteractionMEN1 interactions

PAXIP1 SCAF11 SMARCC2 GIGYF2 NCOA6

2.01e-041029125int:MEN1
InteractionTP53BP1 interactions

PAXIP1 SMARCC2 NCOA3 NCOA6

2.02e-04533124int:TP53BP1
InteractionDPY30 interactions

PAXIP1 PRRC2B NCOA6

2.10e-04204123int:DPY30
InteractionNUP62CL interactions

TRIM24 TOX3

2.14e-0437122int:NUP62CL
InteractionNR4A1 interactions

NCOA2 SMARCC2 NCOA3

2.35e-04212123int:NR4A1
InteractionNR5A2 interactions

NCOA2 NCOA3

2.63e-0441122int:NR5A2
InteractionNCOA3 interactions

NCOA2 SMARCC2 NCOA3

2.77e-04224123int:NCOA3
InteractionYWHAH interactions

NCOA2 TFEB GIGYF2 NCOA3 NCOA6

2.78e-041102125int:YWHAH
InteractionANKRD17 interactions

TRIM24 PRRC2B GIGYF2

2.84e-04226123int:ANKRD17
InteractionNFIX interactions

PAXIP1 TRIM24 SMARCC2

2.88e-04227123int:NFIX
InteractionRORC interactions

NCOA3 NCOA6

3.17e-0445122int:RORC
InteractionHSF1 interactions

TRIM24 PRRC2B GIGYF2 NCOA6

3.37e-04609124int:HSF1
InteractionRORB interactions

NCOA3 NCOA6

3.46e-0447122int:RORB
InteractionEYA4 interactions

NCOA2 PRRC2B NCOA3

3.51e-04243123int:EYA4
InteractionASF1A interactions

TRIM24 SMARCC2 NCOA6

3.78e-04249123int:ASF1A
GeneFamilyAtaxins|Trinucleotide repeat containing

PAXIP1 GIGYF2 NCOA3 TOX3

3.56e-102594775
GeneFamilyBasic helix-loop-helix proteins

NCOA2 TFEB NCOA3

1.79e-0511093420
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

NCOA2 NCOA3

2.98e-051792486
GeneFamilyRing finger proteins

SCAF11 TRIM24

7.73e-032759258
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

NCOA2 BMP2K TRIM24 GIGYF2 NCOA3

2.40e-05856125M4500
CoexpressionGREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB

SCAF11 TRIM24 NCOA3

3.52e-05145123M2137
CoexpressionGSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP

NCOA2 BMP2K PRRC2B

8.75e-05197123M5363
CoexpressionGSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN

TFEB NCOA3 NCOA6

9.15e-05200123M9472
CoexpressionFLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP

SCAF11 NCOA2 BMP2K NCOA3

9.41e-05568124M4023
CoexpressionBOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN

BMP2K TFEB

1.34e-0438122M11778
CoexpressionTBK1.DF_DN

SCAF11 PRRC2B NCOA3

2.63e-04286123M2864
CoexpressionHELLER_HDAC_TARGETS_UP

NCOA2 BMP2K NCOA3

3.56e-04317123M3335
CoexpressionGRESHOCK_CANCER_COPY_NUMBER_UP

NCOA2 TRIM24 TFEB

3.76e-04323123M9150
CoexpressionBILD_CTNNB1_ONCOGENIC_SIGNATURE

SCAF11 NCOA3

5.81e-0479122M7102
CoexpressionWANG_HCP_PROSTATE_CANCER

BMP2K TFEB

1.04e-03106122M17044
CoexpressionHAY_BONE_MARROW_FOLLICULAR_B_CELL

TFEB NCOA3

1.86e-03142122M39198
CoexpressionGSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP

NCOA2 NCOA6

2.15e-03153122M9151
CoexpressionGSE21033_3H_VS_24H_POLYIC_STIM_DC_UP

TRIM24 NCOA6

2.52e-03166122M7722
CoexpressionGSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP

SCAF11 NCOA3

2.64e-03170122M5657
CoexpressionGSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP

SCAF11 NCOA3

2.68e-03171122M5655
CoexpressionGSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP

TFEB PRRC2B

2.83e-03176122M6882
CoexpressionPATIL_LIVER_CANCER

NCOA2 TRIM24 NCOA3

2.95e-03660123M1195
CoexpressionGSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP

PRRC2B NCOA3

3.12e-03185122M5643
CoexpressionGSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP

NCOA2 BMP2K

3.22e-03188122M8452
CoexpressionGSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP

SCAF11 SMARCC2

3.26e-03189122M9978
CoexpressionKASLER_HDAC7_TARGETS_1_UP

NCOA2 NCOA3

3.36e-03192122M2317
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL

SCAF11 NCOA2

3.39e-03193122M6813
CoexpressionVEGF_A_UP.V1_DN

SCAF11 NCOA3

3.39e-03193122M2675
CoexpressionGSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP

NCOA2 BMP2K

3.39e-03193122M6730
CoexpressionKASLER_HDAC7_TARGETS_1_UP

NCOA2 NCOA3

3.43e-03194122MM910
CoexpressionGSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP

SCAF11 PRRC2B

3.43e-03194122M3321
CoexpressionGSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP

PAXIP1 GIGYF2

3.46e-03195122M8134
CoexpressionGSE11057_CD4_CENT_MEM_VS_PBMC_DN

BMP2K TFEB

3.46e-03195122M3117
CoexpressionGSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN

SCAF11 GIGYF2

3.46e-03195122M9824
CoexpressionGSE3982_MEMORY_CD4_TCELL_VS_TH2_UP

TFEB NCOA6

3.50e-03196122M5381
CoexpressionGSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN

TFEB NCOA3

3.50e-03196122M3085
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL

SCAF11 NCOA2

3.50e-03196122MM667
CoexpressionGSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP

SMARCC2 NCOA3

3.53e-03197122M8337
CoexpressionGSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN

BMP2K TFEB

3.53e-03197122M5385
CoexpressionGSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP

PAXIP1 GIGYF2

3.53e-03197122M9569
CoexpressionGSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN

PAXIP1 SMARCC2

3.53e-03197122M5475
CoexpressionGSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN

TFEB GIGYF2

3.53e-03197122M6107
CoexpressionGSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN

TFEB NCOA3

3.53e-03197122M5853
CoexpressionGSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP

PRRC2B GIGYF2

3.57e-03198122M5580
CoexpressionGSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP

SMARCC2 GIGYF2

3.57e-03198122M5341
CoexpressionGSE22886_NAIVE_TCELL_VS_NKCELL_DN

NCOA2 GIGYF2

3.57e-03198122M4415
CoexpressionGSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP

BMP2K TFEB

3.57e-03198122M5544
CoexpressionGSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN

NCOA2 NCOA6

3.57e-03198122M6511
CoexpressionGSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP

BMP2K TOX3

3.60e-03199122M8396
CoexpressionGSE29949_MICROGLIA_VS_DC_BRAIN_UP

BMP2K PRRC2B

3.60e-03199122M8399
CoexpressionGSE14308_TH17_VS_NAIVE_CD4_TCELL_DN

GIGYF2 TOX3

3.60e-03199122M3384
CoexpressionGSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP

SCAF11 TOX3

3.60e-03199122M5978
CoexpressionGSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP

NCOA3 NCOA6

3.60e-03199122M5753
CoexpressionGSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN

TFEB GIGYF2

3.60e-03199122M9532
CoexpressionGSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP

BMP2K TFEB

3.60e-03199122M7156
CoexpressionGSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN

SMARCC2 NCOA3

3.60e-03199122M7865
CoexpressionGSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN

PAXIP1 GIGYF2

3.60e-03199122M8974
CoexpressionGSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP

TRIM24 PRRC2B

3.60e-03199122M8767
CoexpressionGSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN

GIGYF2 NCOA3

3.60e-03199122M9195
CoexpressionGSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN

NCOA2 GIGYF2

3.60e-03199122M316
CoexpressionGSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP

BMP2K TRIM24

3.64e-03200122M7294
CoexpressionGSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN

TFEB NCOA3

3.64e-03200122M9492
CoexpressionGSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN

NCOA2 BMP2K

3.64e-03200122M8196
CoexpressionGSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP

NCOA3 NCOA6

3.64e-03200122M3751
CoexpressionGSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN

BMP2K NCOA3

3.64e-03200122M7028
CoexpressionGSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP

TFEB NCOA6

3.64e-03200122M9447
CoexpressionGSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP

BMP2K NCOA6

3.64e-03200122M9671
CoexpressionGSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN

NCOA2 SMARCC2

3.64e-03200122M8106
CoexpressionGSE40655_FOXO1_KO_VS_WT_NTREG_UP

PRRC2B NCOA6

3.64e-03200122M9439
CoexpressionGSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP

TFEB NCOA3

3.64e-03200122M7742
CoexpressionGSE369_SOCS3_KO_VS_WT_LIVER_DN

NCOA2 PRRC2B

3.64e-03200122M5963
CoexpressionGSE27786_NKTCELL_VS_NEUTROPHIL_DN

TFEB NCOA6

3.64e-03200122M4869
CoexpressionGSE6875_WT_VS_FOXP3_KO_TREG_UP

PRRC2B NCOA3

3.64e-03200122M6803
CoexpressionGSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP

BMP2K TRIM24

3.64e-03200122M6618
CoexpressionGSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN

SCAF11 NCOA3

3.64e-03200122M6601
CoexpressionGSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP

NCOA3 NCOA6

3.64e-03200122M8026
CoexpressionGSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP

BMP2K NCOA3

3.64e-03200122M3605
CoexpressionGSE40273_GATA1_KO_VS_WT_TREG_DN

BMP2K NCOA3

3.64e-03200122M9133
CoexpressionGSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP

NCOA2 BMP2K

3.64e-03200122M3620
CoexpressionGSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP

NCOA2 BMP2K

3.64e-03200122M3623
CoexpressionGSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP

BMP2K NCOA3

3.64e-03200122M3614
CoexpressionGSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN

SCAF11 BMP2K

3.64e-03200122M4979
CoexpressionGSE360_CTRL_VS_L_MAJOR_MAC_UP

PRRC2B SMARCC2

3.64e-03200122M5160
CoexpressionGSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP

PAXIP1 TRIM24

3.64e-03200122M6245
CoexpressionGSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP

BMP2K NCOA6

3.64e-03200122M6262
CoexpressionGSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN

TFEB NCOA3

3.64e-03200122M6021
CoexpressionGSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN

SCAF11 BMP2K

3.64e-03200122M5005
CoexpressionGSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP

PRRC2B NCOA6

3.64e-03200122M5231
CoexpressionGSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN

TRIM24 GIGYF2

3.64e-03200122M7686
CoexpressionGSE6674_CPG_VS_PL2_3_STIM_BCELL_DN

BMP2K NCOA6

3.64e-03200122M6938
CoexpressionGSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN

TFEB NCOA6

3.64e-03200122M5851
CoexpressionGSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN

TFEB NCOA6

3.64e-03200122M5859
CoexpressionGSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN

TFEB NCOA6

3.64e-03200122M5870
CoexpressionGSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP

BMP2K TFEB

3.64e-03200122M7831
CoexpressionSHEPARD_BMYB_MORPHOLINO_DN

PAXIP1 TOX3

3.71e-03202122M11840
CoexpressionTABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING

BMP2K PRRC2B NCOA3

3.82e-03723123MM3672
CoexpressionSTARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP

PRRC2B SMARCC2

3.85e-03206122M2817
CoexpressionSTARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP

PRRC2B SMARCC2

3.93e-03208122MM581
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000

SCAF11 TRIM24 GIGYF2 NCOA3 TOX3

5.20e-05815125gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

PAXIP1 SCAF11 TRIM24 TOX3 NCOA6

4.02e-041257125facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000

TRIM24 GIGYF2 NCOA3

4.34e-04275123gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3

SCAF11 NCOA2 NCOA6

5.11e-04291123Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000

NCOA2 PRRC2B GIGYF2

6.26e-04312123gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000

TRIM24 GIGYF2 NCOA3

6.93e-04323123gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1

SCAF11 NCOA2 NCOA3 NCOA6

7.06e-04780124Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000

SCAF11 TRIM24 GIGYF2 NCOA3

7.41e-04790124gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000

SCAF11 TRIM24 GIGYF2 NCOA3

7.81e-04801124gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

SCAF11 TRIM24 GIGYF2 NCOA3

7.92e-04804124gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

PAXIP1 SCAF11 TRIM24 TOX3 NCOA6

8.00e-041459125facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCelldroplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP2K GIGYF2 TOX3

1.12e-051691235f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

SCAF11 NCOA2 GIGYF2

1.49e-0518612303db813598b67b1e08f759758a1c2023396921fa
ToppCellCTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class

BMP2K TFEB NCOA3

1.56e-0518912314f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

SCAF11 TRIM24 TOX3

1.64e-05192123916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

SCAF11 TRIM24 TOX3

1.66e-05193123e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellCF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class

BMP2K TFEB NCOA3

1.66e-051931237ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCellBronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

BMP2K TFEB NCOA3

1.71e-051951233311a1bf4ed94820b45047d44fc14b14ac72e6fb
ToppCellCOVID-19-COVID-19_Convalescent-Lymphocyte-B-B_intermediate|COVID-19_Convalescent / Disease, condition lineage and cell class

BMP2K TFEB NCOA3

1.85e-05200123fdc0df661a34e0db3279334bdeebfdf60c85ef41
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|390C / Donor, Lineage, Cell class and subclass (all cells)

PAXIP1 TFEB

7.61e-04155122afdd0aba0f3788c2fb916ffb453c5dd7cde2304c
ToppCellB_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

BMP2K TFEB

8.51e-04164122f45013706a917f0f0d69c23f288128f252cd60c7
ToppCelldroplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM24 TOX3

8.82e-04167122a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TFEB TOX3

8.82e-04167122edc5f04584b44f99ff9a62bbe0dab6fc044fb334
ToppCellChildren_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TFEB NCOA3

9.14e-04170122e421f9eedf74baffda1d03707a710ece4b777f29
ToppCellfacs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP2K TRIM24

9.24e-041711226a0fafb8fd9fc7671618eeb2bf528ce8ce86b794
ToppCellfacs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP2K TRIM24

9.24e-04171122e02b5831768dbb1b68998b672e55c9680ab0cc86
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BMP2K TFEB

9.57e-0417412216204ff504b7b382b4d90ca35003ad5336020e07
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PAXIP1 BMP2K

9.68e-04175122334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCell390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

PAXIP1 BMP2K

9.68e-04175122da191dfb8a7f976a632a3a0b923942ab54f5c8c1
ToppCellCOVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations)

TFEB NCOA3

9.90e-04177122653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9

NCOA3 NCOA6

1.00e-03178122edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCellChildren_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

TFEB NCOA3

1.02e-0318012240a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCelldroplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.05e-03182122eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TFEB NCOA3

1.05e-03182122626aabfd9ac662c1d189f7c4b660482914d9e669
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TFEB NCOA3

1.05e-03182122a00abff41c12b71d5860c494b8c722d649fd5f36
ToppCelldroplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.06e-031831223fa608aa6b119869ec3280dc388dfee57160e63a
ToppCellB_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

BMP2K TFEB

1.06e-03183122bf9c6fe3ce4e44e4056027257eab8448c39c4fb8
ToppCelldroplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.06e-0318312228cbf909424f3be4491d49832f0aca0386560814
ToppCellpdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

NCOA3 TOX3

1.08e-031851221d874608aa2062024323512f68889219471b2f00
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TRIM24 TOX3

1.09e-0318612210565fce7e1b4ec88bc8e1ed6410a83800be5014
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TFEB NCOA3

1.09e-03186122d7d884ff4184636081c350d29f797bd923c6a3b4
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

BMP2K PRRC2B

1.09e-0318612274c238759c5d3fd39127ec0060d0c2cb16b326d4
ToppCellChildren_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

TFEB NCOA3

1.09e-03186122aa576748921a318798b911a611f05319b95e8d5e
ToppCellIPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class

BMP2K NCOA3

1.10e-03187122af1327559f7e01bec070881cae52834917c3da65
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9

NCOA3 NCOA6

1.12e-0318812214bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCelldroplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.14e-03190122ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2
ToppCellCOPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class

BMP2K NCOA3

1.14e-031901221e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.15e-0319112209db184cb90fe282a14474d7217068c58092c6f8
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.15e-0319112260c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue

BMP2K TFEB

1.15e-03191122c3ca8077da8594fb493e47ac4dfbbd20bfc14b37
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.15e-03191122973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellmoderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TFEB NCOA3

1.16e-03192122ae3727503c3b9f4695e565fd3161cc33b898f349
ToppCellCOVID-19_Severe-Lymphoid_B-B_intermediate|COVID-19_Severe / Disease group, lineage and cell class

TFEB NCOA3

1.17e-03193122ea079e6f7242a2bbc8260299ad9e9bdabb9856f8
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.17e-0319312206b65110db974f4ef90d3511ff34428976a52c9c
ToppCellhuman_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

TRIM24 TOX3

1.17e-03193122503a979328c68b096680b71359a26f02fafdff35
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TFEB NCOA3

1.17e-03193122437ae3b10d169bb371f7b92d57a77f43e3f8d64d
ToppCellB_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

BMP2K NCOA3

1.17e-03193122b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TFEB NCOA3

1.17e-03193122b5e44fe60dc84dc050d4fa3ccec4e257e51dc636
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.17e-031931229c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TFEB NCOA3

1.17e-03193122e2cf2f4f142e1b4dda3ded28b5208eef3f301a43
ToppCellfacs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.17e-03193122a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.17e-03193122b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)

TFEB NCOA3

1.17e-0319312294b5a4a4e9faaa95cb72907a2f0497429c72e516
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

SCAF11 GIGYF2

1.17e-03193122abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TFEB NCOA3

1.19e-031941222b5eee7c3e52b63cce94205d18133c7704329c02
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TFEB NCOA3

1.19e-031941227f62bd52779e2779447b23bdd330be4b5b35910a
ToppCellB_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

BMP2K NCOA3

1.19e-0319412222b87fe2bb84632ddcef8f1d7742021728e2246d
ToppCellcontrol-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TFEB NCOA3

1.19e-03194122a5284adca931a78b1c4592925c4860853ebd24f1
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TFEB NCOA3

1.19e-03194122f0c113edb706d53792892115b67277a285219942
ToppCellremission-B_intermediate|World / disease stage, cell group and cell class

TFEB NCOA3

1.19e-0319412278556b60c84c7bbffa1c8bf8684b3c427512da44
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue

BMP2K TFEB

1.19e-03194122b57ae94a092b58623a244a258b4659a3864542c7
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

BMP2K NCOA3

1.19e-03194122d852aebf7a763b9a776c4570711f0c759f591910
ToppCellremission-B_intermediate|remission / disease stage, cell group and cell class

TFEB NCOA3

1.20e-03195122ee14d00eb5800fadd57c2304e9461534d8668674
ToppCellPBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters

SCAF11 NCOA3

1.20e-03195122674355ca00314bde90ef7f6ddb83afe2d5323130
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue

TFEB NCOA3

1.20e-031951228b307079cee67fc1df55277d0cab21ea4b97e552
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BMP2K TFEB

1.20e-03195122e0b16ba18092e235d37c67f0762c80a5ec1714f8
ToppCellfacs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAXIP1 PRRC2B

1.20e-03195122bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TFEB NCOA3

1.20e-03195122f43dacc972dc4df574c4639952d3be9fc4201d33
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

BMP2K TFEB

1.20e-0319512230eccfc08106627fae49b93094bbb40fd6888db2
ToppCellfacs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 BMP2K

1.20e-03195122a1478021a3ed0e779716393124ca2a7770c433b7
ToppCellsevere-B_intermediate|World / disease stage, cell group and cell class

BMP2K TFEB

1.20e-03195122ce4bd004ceb05a269387adfed255d7fa393afcc6
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-GC_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TFEB NCOA3

1.21e-03196122d08f6143d148a897efacc854e4306455a9a9868c
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue

TFEB NCOA3

1.21e-03196122c450cd6b799932f5cce8326d1079114abeb71e95
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TFEB NCOA3

1.22e-03197122fa3cc33c975648172feabb485c3bdd087f1f8ea7
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue

TFEB NCOA3

1.22e-031971229837bd2cc28b79147fb5d1997631ef953fd020e4
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BMP2K TOX3

1.24e-03198122ad9fb53cd216af9bc9998d6b3bd0255b45e0dbfb
ToppCellmLN-(2)_B_cell-(22)_B_cell_memory|mLN / shred on region, Cell_type, and subtype

TFEB NCOA3

1.24e-031981224d189df1db5b41306e9653436d7d7e75ff5afa06
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BMP2K TOX3

1.24e-03198122edf3e1c2be9df5690492b9c8fc25e7e48ed5c92c
ToppCell3'-GW_trimst-1-LargeIntestine-Epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BMP2K TOX3

1.24e-031981227c4993be089979e79ca1a160c0c4059c422eac6d
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B|lymph-node_spleen / Manually curated celltypes from each tissue

TFEB NCOA3

1.24e-031981221780fa1725a321041094e8c4430673c0a4f3d407
ToppCellmLN-B_cell-B_cell_memory|mLN / Region, Cell class and subclass

TFEB NCOA3

1.24e-031981226dc155ee487abb1319a60a7a70e84c28c9851985
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

SCAF11 TRIM24

1.24e-0319812276d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type.

TRIM24 TOX3

1.25e-03199122358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCellmLN-(2)_B_cell|mLN / shred on region, Cell_type, and subtype

TFEB NCOA3

1.25e-031991229464c8c72a6b2e14a27b413cc1f5d64550212776
ToppCellsevere-B_memory|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TFEB NCOA3

1.25e-031991226d3436dd65d525aaa23ec02672005380f21c4d0f
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-B-B_intermediate|COVID-19_Severe / Disease, condition lineage and cell class

TFEB NCOA3

1.25e-03199122ad3c369a67926725917b771094f82ca6dd2af783
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TFEB NCOA3

1.25e-031991221aa963ed5205d6d52262b1597a5d08707a95c3ca
ToppCellsevere-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TFEB NCOA3

1.25e-0319912217283d75a2a900369f63ed02996e7ede97f46140
ToppCellmLN-B_cell|mLN / Region, Cell class and subclass

TFEB NCOA3

1.25e-0319912299c7d157a1e819ff86c526ffd9b7036ed3514cae
ToppCellMS-Multiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, condition lineage and cell class

TFEB NCOA3

1.26e-03200122e945dd467dc90b8042982051d1bf76b72a4baf5b
ToppCellmild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

BMP2K NCOA3

1.26e-03200122fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCellsevere-B_intermediate|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TFEB NCOA3

1.26e-032001226d0ac3d00400dd5657ee266f7b885381bf790ce1
Drugirinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A

NCOA2 TRIM24 GIGYF2 NCOA3

1.45e-061711247535_DN
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

SCAF11 NCOA2 GIGYF2 NCOA3

1.90e-061831247498_DN
Drugbutamben

NCOA2 NCOA3

3.82e-066122ctd:C004605
Drug2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3

NCOA2 NCOA3

1.40e-0511122ctd:C061137
DrugAC1L2E0P

NCOA2 TRIM24 NCOA3 NCOA6

1.47e-05307124CID000019390
Drugdihydroxy-vitamin D3

NCOA2 NCOA3

1.98e-0513122ctd:C118756
Drugferutinin

NCOA2 NCOA3

3.04e-0516122CID000354654
Drugandrostenol

NCOA2 NCOA6

8.87e-0527122CID000101989
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

SCAF11 NCOA2 NCOA6

9.17e-051741231659_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

SCAF11 NCOA2 NCOA6

9.65e-051771236972_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

NCOA2 PRRC2B NCOA6

9.81e-051781237245_DN
Drug3-hydroxyflavone

NCOA2 NCOA3

1.03e-0429122ctd:C041477
DrugAzaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A

NCOA2 TRIM24 NCOA3

1.03e-041811231791_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

NCOA2 TRIM24 GIGYF2

1.05e-041821233887_DN
DrugAC1NRAEN

NCOA2 TRIM24

1.10e-0430122CID005287841
Drugtyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA

NCOA2 GIGYF2 NCOA3

1.10e-041851231114_DN
Drugtestosterone-3-carboxymethyloxime-bovine serum albumin conjugate

NCOA2 TRIM24 NCOA6

1.10e-04185123ctd:C045037
DrugCanrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A

NCOA2 BMP2K SMARCC2

1.25e-041931236783_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A

SCAF11 PRRC2B SMARCC2

1.27e-041941231715_DN
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; PC3; HT_HG-U133A

NCOA2 BMP2K PRRC2B

1.27e-041941234263_DN
DrugTrifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A

NCOA2 BMP2K PRRC2B

1.29e-041951233559_DN
DrugThiamphenicol [15318-45-3]; Down 200; 11.2uM; HL60; HT_HG-U133A

BMP2K TFEB PRRC2B

1.29e-041951231867_DN
DrugOxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A

NCOA2 BMP2K SMARCC2

1.29e-041951237225_DN
DrugVerapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A

BMP2K PRRC2B SMARCC2

1.29e-041951231927_UP
DrugMefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A

NCOA2 BMP2K PRRC2B

1.29e-041951235109_DN
DrugEdrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A

PRRC2B SMARCC2 NCOA3

1.31e-041961232019_DN
DrugDomperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A

BMP2K PRRC2B SMARCC2

1.31e-041961231301_DN
DrugOxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A

NCOA2 TFEB PRRC2B

1.31e-041961236309_DN
DrugDiclofenac sodium [15307-79-6]; Down 200; 12.6uM; PC3; HT_HG-U133A

NCOA2 BMP2K PRRC2B

1.31e-041961235861_DN
DrugLY 294002; Up 200; 10uM; HL60; HT_HG-U133A

NCOA2 TFEB NCOA3

1.31e-041961231168_UP
Drugionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA

NCOA2 PRRC2B SMARCC2

1.33e-04197123882_DN
DrugCefaclor [70356-03-5]; Down 200; 10.4uM; HL60; HT_HG-U133A

NCOA2 BMP2K TFEB

1.33e-041971232483_DN
DrugE)-4-hydroxytamoxifen

NCOA2 TRIM24 NCOA3

1.33e-04197123CID000063062
DrugMoxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; HL60; HT_HG-U133A

BMP2K TFEB NCOA3

1.33e-041971231846_DN
Drugrapamycin; Down 200; 0.1uM; HL60; HG-U133A

TFEB PRRC2B NCOA3

1.33e-04197123362_DN
DrugOxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A

NCOA2 BMP2K TFEB

1.33e-041971234530_DN
DrugIsoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; HL60; HT_HG-U133A

NCOA2 TFEB NCOA3

1.33e-041971232463_DN
DrugFuraltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A

NCOA2 PRRC2B NCOA3

1.35e-041981233756_DN
DrugCinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A

NCOA2 PRRC2B SMARCC2

1.35e-041981237174_DN
DrugSulfamethoxazole [723-46-6]; Up 200; 15.8uM; PC3; HT_HG-U133A

NCOA2 SMARCC2 NCOA3

1.37e-041991237366_UP
Drugestradiol; Down 200; 0.01uM; PC3; HT_HG-U133A

BMP2K PRRC2B SMARCC2

1.37e-041991235960_DN
DrugWY-14643; Down 200; 100uM; SKMEL5; HG-U133A

PRRC2B SMARCC2 NCOA3

1.37e-04199123495_DN
DrugAndrostenedione

NCOA2 NCOA3

2.49e-0445122ctd:D000735
Drugvitamin D2

NCOA2 TRIM24 NCOA3

2.49e-04244123CID000003249
DrugAC1ND2OB

NCOA2 TRIM24 NCOA3

3.17e-04265123CID004568637
Drugtris(chloroethyl)phosphate

NCOA2 NCOA3

3.72e-0455122ctd:C031324
DrugAC1NRNSN

NCOA3 NCOA6

4.89e-0463122CID005244174
Druggalangin

NCOA2 NCOA3

5.69e-0468122ctd:C037032
Drughydroxyethylretinamide

NCOA2 NCOA3

6.55e-0473122CID006437840
Drughemi-BABIM

NCOA3 NCOA6

6.92e-0475122CID000001281
Drug4-hydroxytestosterone

NCOA2 NCOA3

7.48e-0478122CID000160615
DrugAldosterone

TRIM24 NCOA6

7.67e-0479122ctd:D000450
Drug5 alpha-androstane

NCOA2 NCOA6

8.67e-0484122CID000094144
Drugtris(2-butoxyethyl) phosphate

NCOA2 NCOA3

8.67e-0484122ctd:C013320
DrugMetribolone

NCOA2 NCOA3 NCOA6

9.21e-04382123ctd:D015741
DrugTCPOBOP

NCOA2 NCOA6

1.11e-0395122CID000005382
Drughydroxyflutamide

NCOA2 NCOA3

1.30e-03103122CID000091649
DrugAC1L1JLU

TRIM24 NCOA6

1.32e-03104122CID000005098
Drug4-HT

TRIM24 NCOA3

1.35e-03105122CID005284643
DrugNevirapine

TRIM24 TOX3

1.67e-03117122ctd:D019829
DrugAC1LCVTP

NCOA3 NCOA6

1.70e-03118122CID000656983
Drugfulvestrant

NCOA2 SMARCC2 NCOA3

1.82e-03484123ctd:C070081
Drug4,4'-hexafluorisopropylidene diphenol

NCOA2 NCOA3

2.45e-03142122ctd:C583074
DiseaseSquamous cell carcinoma of lung

BMP2K TRIM24

7.47e-0532122C0149782
DiseaseMalignant neoplasm of breast

NCOA2 NCOA3 TOX3 NCOA6

6.83e-041074124C0006142
DiseaseC-reactive protein measurement

SCAF11 TFEB SMARCC2 NCOA6

1.06e-031206124EFO_0004458
DiseaseMammary Neoplasms, Human

NCOA2 NCOA3 TOX3

1.09e-03525123C1257931
DiseaseMammary Carcinoma, Human

NCOA2 NCOA3 TOX3

1.09e-03525123C4704874
DiseaseMammary Neoplasms

NCOA2 NCOA3 TOX3

1.11e-03527123C1458155
DiseaseBreast Carcinoma

NCOA2 NCOA3 TOX3

1.17e-03538123C0678222
Diseaseprostate cancer (is_marker_for)

NCOA2 NCOA3

1.77e-03156122DOID:10283 (is_marker_for)
Diseaseforced expiratory volume

BMP2K PRRC2B NCOA6

3.50e-03789123EFO_0004314
Diseasecoronary artery disease

SCAF11 GIGYF2 NCOA6

1.11e-021194123EFO_0001645
Diseasecancer

TOX3 NCOA6

1.11e-02400122MONDO_0004992
Diseasevital capacity

TRIM24 NCOA3 NCOA6

1.21e-021236123EFO_0004312
Diseasesevere acute respiratory syndrome, COVID-19

NCOA2 TOX3

1.37e-02447122EFO_0000694, MONDO_0100096
Diseasetotal blood protein measurement

NCOA2 NCOA3

1.38e-02449122EFO_0004536
Diseasecognitive function measurement

PAXIP1 NCOA2 GIGYF2

1.81e-021434123EFO_0008354
DiseaseQT interval

NCOA2 PRRC2B

1.91e-02534122EFO_0004682

Protein segments in the cluster

PeptideGeneStartEntry
MQQYQHATQQQQMLQ

BMP2K

501

Q9NSY1
QIQQQQLQRMHQQQQ

PAXIP1

531

Q6ZW49
QLQRMHQQQQQQQMQ

PAXIP1

536

Q6ZW49
PQSQQQQQQQQQMMM

NCOA6

1021

Q14686
RQMQKQQQQQQQHQQ

GIGYF2

1011

Q6Y7W6
QMNVMQQQMNAQHQP

SCAF11

1211

Q99590
QQQAVMHYMQQQQQQ

TFEB

26

P19484
MHYMQQQQQQQQQQL

TFEB

31

P19484
QRVAMMMQQQQQQQQ

NCOA3

1241

Q9Y6Q9
MMQQQQQQQQQQQQQ

NCOA3

1246

Q9Y6Q9
ARQQHFQQMHQQQQQ

SMARCC2

946

Q8TAQ2
HLRQRQMHQQQQVQQ

NCOA2

1246

Q15596
QMHQQQQVQQRTLMM

NCOA2

1251

Q15596
QHMQQQVMAQRQQVQ

TRIM24

471

O15164
QQQQQQQEQLYKMQH

PRRC2B

631

Q5JSZ5
VQTQQHQMQLQQQQQ

TOX3

436

O15405
QQQQQQQQQQMQQMQ

TOX3

446

O15405
QQQQQMQQMQQQQLQ

TOX3

451

O15405
MQQMQQQQLQQHQMH

TOX3

456

O15405
QQQLQQHQMHQQIQQ

TOX3

461

O15405
QHQMHQQIQQQMQQQ

TOX3

466

O15405
QQIQQQMQQQHFQHH

TOX3

471

O15405
MQQHLQQQQQHLQQQ

TOX3

486

O15405